Chr Hansen Holding A/S
CSE:CHR

Watchlist Manager
Chr Hansen Holding A/S Logo
Chr Hansen Holding A/S
CSE:CHR
Watchlist
Price: 549.6 DKK -0.61%
Market Cap: 72.3B DKK
Have any thoughts about
Chr Hansen Holding A/S?
Write Note

Chr Hansen Holding A/S
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chr Hansen Holding A/S
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Chr Hansen Holding A/S
CSE:CHR
Total Liabilities & Equity
€3.4B
CAGR 3-Years
6%
CAGR 5-Years
13%
CAGR 10-Years
10%
Novozymes A/S
CSE:NZYM B
Total Liabilities & Equity
kr28.4B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
N/A
P
Photocat A/S
STO:PCAT
Total Liabilities & Equity
kr22.2m
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Chr Hansen Holding A/S
Glance View

Market Cap
72.3B DKK
Industry
Chemicals

Amid the lush, rolling landscapes of Denmark lies Chr. Hansen Holding A/S, a company with roots tracing back to 1874, when it was founded by the Danish pharmacist Christian D.A. Hansen. Today, Chr. Hansen stands as a global powerhouse and a vanguard in the bioscience industry, revered for its innovative approach to natural ingredient solutions. Anchored in the principles of sustainability and natural alternatives, the company specializes in producing cultures, enzymes, probiotics, and natural colors. These components are integral to a wide swath of industries—from food and beverages to health and agriculture—each product crafted to enhance taste, preservation, nutritional value, and even the health of end consumers and the environment. The engine of Chr. Hansen’s business model is its adeptness at utilizing and fermenting microorganisms, deploying them to solve real-world challenges and enrich various consumer products. This expertise manifests in lucrative partnerships and contracts with dairy producers, meat processors, and producers of dietary supplements, among others. By aligning its products with the trending consumer demand for natural and sustainable solutions, Chr. Hansen ensures robust sales and recurring revenues. Moreover, their commitment to research and development supports a continuous innovation pipeline, reinforcing their market leadership and fuelling further growth across international borders, making Chr. Hansen a quintessential example of science meeting commerce to flourish sustainably.

CHR Intrinsic Value
383.66 DKK
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Chr Hansen Holding A/S's Total Liabilities & Equity?
Total Liabilities & Equity
3.4B EUR

Based on the financial report for Aug 31, 2023, Chr Hansen Holding A/S's Total Liabilities & Equity amounts to 3.4B EUR.

What is Chr Hansen Holding A/S's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
10%

Over the last year, the Total Liabilities & Equity growth was 3%. The average annual Total Liabilities & Equity growth rates for Chr Hansen Holding A/S have been 6% over the past three years , 13% over the past five years , and 10% over the past ten years .

Back to Top